Inpatient deaths from acute myocardial infarction, 1982-92: Analysis of data in the Nottingham heart attack register

British Medical Journal

Volumn 315, Issue 7101, 1997, Pages 159-164

  Brown, Nigel ^a   Young, Tracey ^b   Gray, David ^a   Skene, Allan M ^b   Hampton, John R ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CORONARY CARE UNIT; FEMALE; FIBRINOLYTIC THERAPY; GENERAL HOSPITAL; HOSPITAL ADMISSION; HUMAN; LENGTH OF STAY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RURAL POPULATION; TIME; UNITED KINGDOM; URBAN POPULATION;

EID: 0030814357     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.315.7101.159     Document Type: Article

References (41)

1. Julian DG. The history of coronary care units. Br Heart J 1987; 57:497-502.
2. Hofvendal S. Influence of treatment in a coronary care unit of prognosis in acute myocardial infarction. Acta Med Scand 1971;519(suppl 1):1-78.
3. Christianson I, Iverson K, Skouby AP. Benefits obtained by the introduction of a coronary care unit. Acta Med Scand 1971;189:285-91.
4. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988;ii:349-60.
5. Yusuf S, Peto R, Lewis J, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomised trials. Prog Cardiovasc Dis 1985;27:335-71.
6. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;i:397-402.
7. Wilcox RG, Olsson CG, Skene AM, Von der Lippe G, Jensen G, Hampton JR. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction: Anglo-Scandinavian study of early thrombolysis (ASSET). Lancet 1988;ii:525-30.
8. Appleby P, Baigent C, Collins R, Flather M, Parish S, Peto R, et al. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343:311-22.
9. Clarke KW, Gray D, Hampton JR. Death from ischaemic heart disease in Nottingham 1973-1992. Br Heart J 1995;73(suppl 3):49.
10. Gray D, Keating NA, Murdock J, Skene AM, Hampton JR. Impact of hospital thrombolysis policy on out-of-hospital response to suspected myocardial infarction. Lancet 1993;341:654-7.
11. Killip T, Kimball JT. Treatment of myocardial infarction in a coronary care unit: two years' experience with 250 patients. Am J Cardiol 1967;20:457-64.
12. S-plus guide to statistical and mathematical analysis. Version 3.2. Seattle: Stat Sci, 1993.
13. Central Statistical Office. Regional trends 27. London: HMSO, 1992.
14. Rowley JM, Mounser P, Harrison EA, Skene AM, Hampton JR. Management of myocardial infarction: implications for current policy derived from the Nottingham heart attack register. Br Heart J 1992;67:255-62.
15. Naylor CD, Chen E. Population-wide mortality trends among patients hospitalised for acute myocardial infarction: the Ontario experience, 1981 to 1991. J Am Coll Cardiol 1994;24:1431-8.
16. Gray D, Keating N, Skene AM, Hampton JR. Myocardial infarction in patients over 75, 1982-1990. QJ Med 1992;84:659-69.
17. Clarke KW, Gray D, Keating NA, Hampton JR. Do women with acute myocardial infarction receive the same treatment as men? BMJ 1994;309:563-6.
18. Thanavaro S, Krone RJ, Kleiger RE, Province MA, Miller JP, de Mello VR, et al. In-hospital prognosis of patients with first nontransmural and transmural infarctions. Circulation 1980;61:29-33.
19. Ulvenstam G, Aberg A, Bergstrand R, Johansson S, Pennert K, Vedin A, et al. Recurrent myocardial infarction. 1. Natural history of fatal and nonfatal events. Eur Heart J 1985;6:294-302.
20. Goldberg RJ, Gore JM, Alpert JS, Dalen JE. Non-Q wave myocardial infarction: recent changes in occurrence and prognosis - a community-wide perspective. Am Heart J 1987;113:273-9.
21. Nicod P, Gilpin E, Dittrich H, Polikar R, Hjalmarson A, Blacky AR, et al. Short and long-term clinical outcome after Q wave and non-Q wave myocardial infarction in a large patient population. Circulation 1989;79:528-36.
22. Ogawa H, Hiramori K, Haze K, Saito M, Sumiyoshi T, Fukami K, et al. Comparison of clinical features of non-Q wave and Q wave myocardial infarction. Am Heart J 1986;111:513-8.
23. Zema MJ. Q wave, S-T segment, and T wave myocardial infarction. Useful clinical distinction. Am J Med 1985;78:391-8.
24. Edlavitch SA, Crow R, Burke GL, Baxter J. Secular trends in Q wave and non-Q wave acute myocardial infarction. The Minnesota heart survey. Circulation 1991;83:492-503.
25. Spodick DH. Q-wave infarction versus S-T infarction. Nonspecificity of electrocardiographic criteria for differentiating transmural and nontransmural lesions. Am J Cardiol 1983;51:913-5.
26. Phibbs B. "Transmural" versus "subendocardial" myocardial infarction: an electrocardiographic myth. J. Am Coll Cardiol 1983;1:561-4.
27. Gore JM, Goldberg RJ, Alpert JS, Dalen JE. The increased use of diagnostic procedures in patients with acute myocardial infarction. A community-wide perspective. Arch Intern Med 1987;147:1729-32.
28. McGovern PG, Folsom AR, Sprafka JM, Burke GL, Doliszny KM, Demirovic J, et al. Trends in survival of hospitalized myocardial infarction patients between 1970 and 1985. The Minnesota heart survey. Circulation 1992;85:172-9.
29. Rogers WJ, Epstein AK, Arciniegas JG, Dailey SM, Kay GN, Little RE, et al. Preliminary report: effect of encainide and flecainide on mortality in a randomised trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989;321:406-12.
30. Collins R, Julian D. British Heart Foundation surveys (1987 and 1989) of United Kingdom treatment policies for acute myocardial infarction. Br Heart J 1991;66:250-5.
31. Pashos CL, Normand SLT, Garfinkle JB, Newhouse JP, Epstein AM, McNeil BJ. Trends in the use of drug therapies in patients with acute myocardial infarction: 1988 to 1992. J Am Coll. Cardiol 1994;23:1023-30.
32. Gheorghiade M, Ruzumna P, Borzak S, Havstad S, Ali A, Goldstein S. Decline in the rate of hospital mortality from acute myocardial infarction: impact of changing management strategies. Am Heart J 1996;131:250-6.
33. Ketley D, Woods KL. Impact of clinical trials on clinical practice: example of thrombolysis for acute myocardial infarction. Lancet 1993;342:891-4.
34. Hampton J, Wilcox R, Armstrong P, Aylward P, Bett N, Charbonnier B, et al. Late assessment of thrombolytic efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction. Lancet 1993;342:759-66.
35. Higgins MW, Luepker RV. Trends in coronary heart disease mortality: the influence of medical care. New York: Oxford University Press, 1988.
36. Goldman L, Cook EF. The decline in ischemic heart disease mortality rates. An analysis of the comparative effects of medical interventions and changes in lifestyle. Ann Intern Med 1984;101:825-36.
37. Sytkowski PA, Kannel WB, Dagostino RB. Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham heart study. N Engl J Med 1990;322:1635-41.
38. Goldman L, Cook F, Hashimoto B, Stone P, Muller J, Loscalzo A. Evidence that hospital care for acute myocardial infarction has not contributed to the decline in coronary mortality between 1973-1974 and 1978-1979. Circulation 1982;65:936-42.
39. Goldberg RJ, Gorak EJ, Yarzebski J, Hosmer DW Jr, Dalen P, Gore JM, et al. A communitywide perspective of sex differences and temporal trends in the incidence and survival rates after acute myocardial infarction and out-of-hospital deaths caused by coronary heart disease. Circulation 1993;87:1947-53.
40. Dellborg M, Eriksson P, Riha M, Swedberg K. Declining hospital mortality in acute myocardial infarction. Eur Heart J 1994;15:5-9.
41. Greenbaum RA, Morris Rb Sritara P, Shanit D, Chan KL. Reduced in-hospital mortality from acute myocardial infarction with general adoption of thrombolytic treatment in the North West Thames health region 1979-1991. Br Heart J 1995;74:493-6.